Short to Mid-Term Outcomes in Patients Bridged to Recovery Using Impella 5.5

Purpose: In the setting of cardiogenic shock, Impella 5.5 is increasingly utilized as a minimally invasive bridge to recovery, decision, durable left ventricular assist device, or heart transplantation. We studied our short to mid-term experience with patients weaned from Impella 5.5.

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: E. Faridmoayer, G. Dardik, T.R. Powley, A.P. Lin, M. Biscotti, J.R. Gower, J.A. Fried, M. Yuzefpolskaya, P.C. Colombo, G.T. Sayer, N. Uriel, G. Ferrari, K. Takeda, Source Type: research